All stock lists
Unlock the score
Braveheart Bio, Inc. (NASDAQ:BRVE)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
21.66+0.22 (+1.04%)
Market cap
$1.53B
Insider Score
Analyst consensus
Listed since
Aug 6, 2026
Website
Insider Score
/ 100
BRVE Insider Score
Braveheart Bio, Inc. has a live Insider Score.
Scored on 10 qualifying trades from 8 insiders in the last 90 days.
Braveheart Bio, Inc. Executive Compensation
Reading the latest SEC DEF 14A proxy…
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.